Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -.--% | -.--% |
May. 21 | Macquarie Upgrades Harvey Norman to Outperform From Neutral, Price Target is AU$5.30 | MT |
Feb. 29 | Australian Shares Rebound Ahead of Key US Inflation Data | MT |
Sales 2024 * | 4.17B 2.77B 2.5B | Sales 2025 * | 4.38B 2.91B 2.63B | Capitalization | 5.56B 3.7B 3.33B |
---|---|---|---|---|---|
Net income 2024 * | 368M 245M 221M | Net income 2025 * | 428M 285M 257M | EV / Sales 2024 * | 1.88 x |
Net Debt 2024 * | 2.27B 1.51B 1.36B | Net Debt 2025 * | 2.34B 1.56B 1.41B | EV / Sales 2025 * | 1.8 x |
P/E ratio 2024 * |
15.1
x | P/E ratio 2025 * |
13
x | Employees | - |
Yield 2024 * |
4.97% | Yield 2025 * |
5.57% | Free-Float | 41.02% |
Managers | Title | Age | Since |
---|---|---|---|
Kay Page
CEO | Chief Executive Officer | 67 | 82-12-31 |
Chris Mentis
DFI | Director of Finance/CFO | 58 | 97-12-14 |
Glen Gregory
CTO | Chief Tech/Sci/R&D Officer | - | 19-09-08 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Harvey
FOU | Founder | 85 | 82-09-30 |
Kay Page
CEO | Chief Executive Officer | 67 | 82-12-31 |
Director/Board Member | 59 | 86-12-31 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.93% | 19.39B | |
+112.58% | 7.79B | |
+26.41% | 7.6B | |
+10.83% | 7.25B | |
+10.25% | 6.98B | |
-3.33% | 5.77B | |
-3.18% | 5.38B | |
+39.04% | 5.37B | |
-13.50% | 3.31B |
- Stock Market
- Equities
- HVN Stock
- HNN Stock